000 | 01221 a2200361 4500 | ||
---|---|---|---|
005 | 20250513062851.0 | ||
264 | 0 | _c19940510 | |
008 | 199405s 0 0 eng d | ||
022 | _a0362-5664 | ||
024 | 7 |
_a10.1097/00002826-199402000-00008 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBonifati, V | |
245 | 0 | 0 |
_aBuspirone in levodopa-induced dyskinesias. _h[electronic resource] |
260 |
_bClinical neuropharmacology _cFeb 1994 |
||
300 |
_a73-82 p. _bdigital |
||
500 | _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBuspirone _xtherapeutic use |
650 | 0 | 4 | _aDouble-Blind Method |
650 | 0 | 4 |
_aDyskinesia, Drug-Induced _xdrug therapy |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLevodopa _xadverse effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aParkinson Disease _xcomplications |
700 | 1 | _aFabrizio, E | |
700 | 1 | _aCipriani, R | |
700 | 1 | _aVanacore, N | |
700 | 1 | _aMeco, G | |
773 | 0 |
_tClinical neuropharmacology _gvol. 17 _gno. 1 _gp. 73-82 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00002826-199402000-00008 _zAvailable from publisher's website |
999 |
_c8148683 _d8148683 |